Comparison

Ketamine vs lithium augmentation

Lithium augmentation has decades of evidence in treatment-resistant depression. Ketamine offers faster relief but less long-term outcome data. They are sometimes used together.

Written by: Ira ZootMedical review status: Not yet clinically reviewed.Last updated: June 4, 2026Evidence: Educational synthesis - not medical advice

This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.

Quick answer

Bottom line

These work on different timescales and can complement each other. Lithium has the better long-term outcome record; ketamine has the faster onset.

This page compares Ketamine and Lithium augmentation across the same fixed dimensions - mechanism, evidence, onset, duration, side effects, access, suitability, and limits. It does not name a winner and does not recommend either option for you.

Related on Ketalux

Ketamine

Lithium augmentation

Mechanism

NMDA antagonism, glutamate surge, plasticity.

Modulates intracellular signaling (GSK-3, inositol), monoamines, and neuroprotection.

Evidence

Strong short-term TRD response.

Robust long-term TRD augmentation evidence; reduces suicidality.

Onset

Hours to days.

Two to six weeks.

Duration

Days to weeks; requires maintenance.

Ongoing while taken; monitored levels.

Side effects

Transient dissociation, BP, nausea.

Tremor, thyroid and kidney effects, weight gain; requires blood monitoring.

Access

Specialty clinics.

Psychiatry; standard prescription.

Best for

Rapid relief; patients seeking non-daily treatment.

Long-term TRD management, suicidality reduction, bipolar spectrum considerations.

Limits

Less long-term outcome data.

Side-effect burden; lab monitoring required.

Disclaimer

This comparison is educational and general. It is not a recommendation. Treatment choice depends on your individual history, diagnosis, prior response, preferences, and access - discuss with a qualified clinician.

About the author

Ira Zoot

Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.